BusinessGalectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development ProgramsBy Nasdaq OMXJan 25, 2018, 1:31 PM UTC
BusinessCourt Date Set for Worlds Inc.’s IPR Appeal Oral ArgumentBy Nasdaq OMXJan 25, 2018, 1:01 PM UTC
BusinessAmarantus Subsidiary Cutanogen Corporation Announces Issuance of US Patent 14/299,480 Covering ESS, Pigmented ESS and Gene Therapy-Modified ESSBy Nasdaq OMXJan 23, 2018, 2:59 PM UTC
BusinessMattersight Issued Four New Patents Signaling the Future of AnalyticsBy Nasdaq OMXJan 9, 2018, 3:45 PM UTC
BusinessLondon Court of Appeal Validates IPCom’s Mobile Telecoms Patent Critical to the UMTS StandardBy Nasdaq OMXJan 9, 2018, 1:00 PM UTC
BusinessAmarantus Subsidiary Cutanogen Corporation Announces Patent Issuance in Hong Kong Covering ESS, Pigmented ESS and Gene Therapy-Modified ESSBy Nasdaq OMXJan 4, 2018, 2:45 PM UTC
BusinessAppTech Retains DiNovo Price LLP to focus on immediate patent and technology licensingBy Nasdaq OMXDec 26, 2017, 1:00 PM UTC
BusinessAmarantus Subsidiary MANF Therapeutics Announces Issuance of Japanese Patent Covering Therapeutic Use of MANF in Treatment of Parkinson's DiseaseBy Nasdaq OMXDec 20, 2017, 2:02 PM UTC
